TRML Tourmaline Bio Inc Net earnings per share growth forecast for next year
Changes in the consensus net profit growth estimate reflect expert expectations, with the metric holding at -11.10. Tourmaline Bio, Inc. (TRML) focuses on developing unique interleukin-1 antibodies to combat rare inflammatory diseases. Aggressive research into the monoclonal antibody TOUR006 opens prospects for atherosclerosis therapy. Positive share price action depends on clinical trial results and new strategic alliances.
Metric breakdowns and analytics for tourmalinebio.com (TRML)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity Tourmaline Bio, Inc.|TRML - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Tourmaline Bio|TRML - Company Aggregate Debts|Debt to Book Capitalization Ratio Tourmaline Bio|TRML - Company Long-Term Loans and Borrowings|Company Short-Term Debt Tourmaline Bio|Quick Ratio tourmalinebio.com
- earnings and valuation multiples information:
TRML - Net Profit|Expected Profit Tourmaline Bio, Inc.|TRML - Price to Earnings Ratio|Forward P/E Multiple Tourmaline Bio, Inc.|TRML - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|TRML - Operating profit before amortization|Net earnings per share (EPS TTM) Tourmaline Bio|TRML - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months tourmalinebio.com|TRML - Earnings per share increase in current year|Earnings growth forecast for next year Tourmaline Bio, Inc.
Basic company analysis:TRML, Tourmaline Corp
This indicator reflects the analysts' consensus valuation regarding the business's future profitability by measuring the expected dynamics of net earnings per share. By analyzing the forward EPS growth forecast, an investor can assess the probability of commercializing the IL-6 inhibitor from Tourmaline Bio, Inc. (TRML), where the rate of change in this metric depends directly on the success of clinical trials and the efficiency of R&D budget utilization.
Competitor analysis for Tourmaline Bio, Inc.
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA: Expected earnings per share growth for next year|Grifols Biemat - Projected earnings per share increase next year|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Expected earnings per share growth for next year AUPH|Earnings growth forecast for next year BioCryst Pharmaceuticals, Inc.|Net earnings per share growth forecast for next year Vera Pharma (VERA)|DNTH (Dianthus Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Pharvaris N.V. PHVS|ABCL - Expected earnings per share growth for next year|Precigen - Earnings growth forecast for next year|PHAR - Earnings growth forecast for next year|Nektar (NKTR) - Net earnings per share growth forecast for next year|UPB (Upstream Pharma) - Net earnings per share growth forecast for next year|ZBIO (Zenas Biopharma Inc) - Earnings growth forecast for next year|immunome.com (IMNM) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Gossamer Bio (GOSS)|KalVista Pharma - Projected earnings per share growth rate for next year|Earnings growth forecast for next year SEPN (Septerna Corp)|Pieris Corp (PVLA) - Expected net earnings per share growth next year|SVRA: Expected earnings per share growth for next year|Expected earnings per share trend next year RIGL (rigel.com)|ANAB: Earnings growth forecast for next year|ATXS (Astria Therapeutics Inc) - Net earnings per share growth forecast for next year|ENGN (enGene Bio) - Earnings growth forecast for next year|RAPT Therapeutics Inc. (RAPT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aerovate Therapeutics Inc (JBIO)|ACRS - Expected net earnings per share growth next year|Kyverna Therapeutics, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year TLSA|Cabaletta Bio, Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Ventyx Biosciences, Inc VTYX|Theratechnologies Inc. (THTX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AVTX|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Agenus, Inc. (AGEN)|Expected earnings per share growth for next year CLYM (Climb Bio, Inc.)|Consensus forecast of earnings per share growth for next year Zura Bio Ltd|aTyr Pharma, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year ADAG (Adagene Inc)|IMA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year STTK (Shattuck Labs, Inc.)|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Connect Biopharma Holdings Limited|Net earnings per share growth forecast for next year Immunic Therapeutics|Net earnings per share growth forecast for next year ATRA|Net earnings per share growth forecast for next year InflaRx N.V. (IFRX)|XFOR: Net earnings per share change forecast for next year|Earnings growth forecast for next year ACET (Adicet Bio, Inc.)|Expected earnings per share trend next year CELU|INmune Bio, Inc. - Earnings growth forecast for next year|BRNS - Earnings growth forecast for next year|Kezar Life Sciences, Inc. (KZR) - Net earnings per share growth forecast for next year|SAB Biotherapeutics Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Expected earnings per share growth for next year Enlivex Therapeutics, Ltd. (ENLV)|Earnings growth forecast for next year QTTB|Earnings growth forecast for next year geovax.com (GOVX)|Edesa Biotech - Expected earnings per share growth for next year|Expected earnings per share trend next year IBIO|Carisma Tx - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year XTL Bio XTLB|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year HCW Biologics|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Expected earnings per share growth for next year ADTX (Aditxt)|Earnings growth forecast for next year GRI Bio Corporation (GRI)|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|HIND: Projected earnings per share growth rate for next year|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Indaptus Therapeutics Inc|SCNI (Scinai) - Expected earnings per share growth for next year|CALI: Projected earnings per share increase next year|Net earnings per share growth forecast for next year Affimed NV|Expected net earnings per share growth next year Allakos Therapeutics ALLK|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|Earnings growth forecast for next year igmbio.com (IGMS)|Net earnings per share growth forecast for next year iTeos ITOS|Expected earnings per share trend next year OCEA|TCBP - Net earnings per share growth forecast for next year|thirdharmonicbio.com (THRD) - Expected earnings per share growth for next year
